ALOMIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Alomide, and when can generic versions of Alomide launch?
Alomide is a drug marketed by Novartis and is included in one NDA.
The generic ingredient in ALOMIDE is lodoxamide tromethamine. One supplier is listed for this compound. Additional details are available on the lodoxamide tromethamine profile page.
Summary for ALOMIDE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 54 |
Patent Applications: | 181 |
Drug Prices: | Drug price information for ALOMIDE |
What excipients (inactive ingredients) are in ALOMIDE? | ALOMIDE excipients list |
DailyMed Link: | ALOMIDE at DailyMed |
Pharmacology for ALOMIDE
Drug Class | Mast Cell Stabilizer |
Physiological Effect | Decreased Histamine Release |
Anatomical Therapeutic Chemical (ATC) Classes for ALOMIDE
US Patents and Regulatory Information for ALOMIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novartis | ALOMIDE | lodoxamide tromethamine | SOLUTION/DROPS;OPHTHALMIC | 020191-001 | Sep 23, 1993 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ALOMIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Novartis | ALOMIDE | lodoxamide tromethamine | SOLUTION/DROPS;OPHTHALMIC | 020191-001 | Sep 23, 1993 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |